NSE filing, NSE: IOLCP. Summary written from the filing by ALFA Finder's alert engine.
IOL Chemicals and Pharmaceuticals Ltd: key numbers
- Share price
- ₹184.93
- Market cap
- ₹5,428 Cr
- Revenue (annual)
- ₹2,319 Cr
- Net profit (annual)
- ₹137.6 Cr
- P/E (TTM)
- 32.3×Sector 48.7×
- Promoter holding
- 62.28%+0.00% QoQ
- FII holding
- 7.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IOL Chemicals and Pharmaceuticals Ltd
All →IOL Chemicals and Pharmaceuticals Board Meeting Date
IOL Chemicals scheduled its board meeting for 30 Oct 2026 to consider unaudited Q1/H1 results. Trading window remains closed until 2 Nov 2026.
IOL Chemicals and Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
IOL Chemicals and Pharmaceuticals Regulatory Approval
IOL Chemicals and Pharmaceuticals Limited received EU-REACH registration for its product 'Triacetin', enabling the company to export this product to countries in the European Union.
IOL Chemicals and Pharmaceuticals Other Announcement
IOL Chemicals and Pharmaceuticals Limited informed the Exchange about the dispatch of reminder letters to shareholders holding physical shares for updating their KYC details.
IOL Chemicals and Pharmaceuticals Earnings Call Transcript: Key Takeaways
IOL Chemicals announced three strategic initiatives involving INR 500 Cr investment: Ibuprofen capacity expansion (to 18,000 MTPA), a new CDMO formulations facility, and a dedicated specialty chemical tolling facility.
- Call
- Guides 20% growth
IOL Chemicals and Pharmaceuticals Capacity Expansion: ₹350 Cr Investment
IOL Chemicals and Pharmaceuticals Ltd will expand Ibuprofen capacity by 6,000 MTPA. The project, requiring a ₹350 Crore investment, is expected to be commercialized by December 2027.
- Value
- ₹350.0 Cr
- Execution
- December 2027
- manufacturing capacity
- 6000.0 MTPA
Other other announcement announcements
All →Lumino Industries Other Announcement
Lumino Industries intimated that its CIN and MCA listing status were updated after its BSE/NSE listing. This is a routine administrative compliance filing with no financial impact.
Aplab Other Announcement
Aplab confirmed zero deviation in utilizing its ₹6.29 Crore rights issue proceeds for Q3 FY27. This is a routine quarterly compliance certificate under SEBI ICDR.
Sathlokhar Synergys E&C Global Other Announcement
Sathlokhar Synergys filed its Q2 FY27 Reg 32 statement confirming no deviation in utilization of preferential issue proceeds. The company utilized ₹737.70 Cr of ₹932.36 Cr received, with no variation from stated objects.
Vardhman Special Steels Other Announcement
Vardhman Special Steels filed the Crisil Monitoring Agency Report for the quarter ended 30 September 2026. It reports no deviation from the preferential issue's use of proceeds.
Three M Paper Boards Other Announcement
Three M Paper Boards filed its Reg 13(3) investor grievance report. All complaint categories for the quarter show NIL figures.
Manika Plastech Other Announcement
Manika Plastech intimated a change in its CIN from U- to L-prefixed code following its September 2026 listing. This is a routine MCA registry update with no transactional or business substance.